SecBot SecBot
3 ·Filed Oct 30, 2026

GANX

Gain Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed18d ago SEC0001104659-26-120731
Form 3: initial insider ownership statement
Actionable Insight • Neutral

Routine new officer Form 3 with zero reported holdings. No trading signal. Monitor future Form 4 filings by this insider for any open-market purchases or grants that would indicate insider conviction.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$1.13
T+0 close · Oct 30, 2026 · via day close
Latest settled
−3.54%
T+5 · $1.09 · next T+20 in 14d
Vs SPY
−3.62%
α at T+5
Latest observation
−9.92%
T+9 · FF3 residual α
  1. T+0 · Nov 2 $1.13entry
  2. T+1 · 14d ago +1.77%α +1.47% · $1.15
  3. T+5 · 8d ago −3.54%α −3.62% · $1.09
  4. T+11 · todayOpen
  5. T+20 · in 14d Pending
  6. T+60 · in 2mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Jeanette Weidner filed a Form 3 initial statement of beneficial ownership with the SEC, reporting no securities owned, and appointed attorneys-in-fact for Section 16 filings. The filing is a routine administrative requirement for a new officer (Principal Accounting Officer and Principal Financial Officer) and contains no material financial information.

Key Facts

  • Jeanette Weidner filed a Form 3 as a new reporting person (Principal Accounting Officer and Principal Financial Officer) of Gain Therapeutics, Inc.
  • The Form 3 reports zero beneficial ownership of the company's securities.
  • A Power of Attorney (Exhibit 24) was included, authorizing Gene Mack, Daniel Porco, and Christopher Williams to act as attorneys-in-fact for Section 16 filings.
  • The filing is dated October 30, 2026, with a period of report of October 28, 2026.

Financial Impact

No financial impact; the filing reports zero securities owned and no transactions.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001104659-26-120731
Document: 0001104659-26-120731-index-headers.html0001104659-26-120731
Document: 0001104659-26-120731-index.html0001104659-26-120731
Document: 0001104659-26-120731.txt0001104659-26-120731

Track record

15 reports on GANX

Performance horizon

2 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +13.74% at T+60 after the May 26, 2026 report. 3 of 6 went positive at some point.

Filters
  1. Nov 17, 2026today Press Release Bullish 6/10 Entry $1.19 Now $1.18 −0.84% settles Nov 25
  2. Nov 10, 20267d ago Press Release Neutral 4/10 Entry $1.08 Now $1.18 +9.26% due Nov 17
  3. Oct 30, 202618d ago 3 Neutral 2/10 Viewing Entry $1.13 to $1.09 Now $1.18 +4.42% ▼ −3.54% −3.62% vs SPY
  4. Oct 28, 202620d ago 8-K Neutral 2/10 Entry $1.19 to $0.9604 Now $1.18 −0.84% ▼ −19.29% −14.57% vs SPY
  5. Oct 1, 20266w ago Press Release Neutral 4/10 Entry $1.72 to $1.62 Now $1.18 −31.40% ▼ −6.10% −7.41% vs SPY
  6. Oct 1, 20266w ago 8-K Bullish 6/10 Entry $1.72 to $1.62 Now $1.18 −31.40% ▼ −6.10% −7.41% vs SPY
  7. Aug 11, 202614w ago Press Release Bullish 6/10 Entry $2.06 to $2.03 Now $1.18 −42.72% ▼ −1.46% −1.05% vs SPY
  8. Jul 16, 202617w ago 8-K Neutral 4/10 Entry $1.66 to $1.82 Now $1.18 −28.92% ▲ +9.64% +11.31% vs SPY
  9. Jun 29, 202620w ago 8-K Bullish 7/10 Entry $2.03 to $1.81 Now $1.18 −41.87% ▼ −10.84% −11.44% vs SPY
  10. Jun 29, 202620w ago Press Release Bullish 5/10 Entry $2.03 to $1.81 Now $1.18 −41.87% ▼ −10.84% −11.44% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens Wed (16h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026